Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_assertion description "[Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_assertion evidence source_evidence_literature NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_assertion SIO_000772 24059322 NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_assertion wasDerivedFrom befree-20150227 NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_assertion wasGeneratedBy ECO_0000203 NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP236221.RAiQ2k7wUBOrbTGjbgQyjZXVzm2GcwrBVSmnOhl3360V8130_provenance.